PTPRO and hepatocellular carcinoma: However, previously reported values for the PD-L1 positive rate suggest that this rate was not particularly high for non-small cell lung cancer and breast cancer2; therefore, we studied the impact of PTPRO on PD-L1 expression in hepatocellular carcinoma (HCC) monocytes and macrophages.